2022
CARDIOVASCULAR DISEASE AND TYPE 2 DIABETES: TREATMENT SATISFACTION, QUALITY OF LIFE AND DIABETES RELATED SYMPTOMS WHEN RECEIVING SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR VERSUS OTHER NONINULIN DIABETES MEDICATIONS
Ding Q, Spatz E, Isaacs D, Bena J, Morrison S, Levay M, West L, Combs P, Albert N. CARDIOVASCULAR DISEASE AND TYPE 2 DIABETES: TREATMENT SATISFACTION, QUALITY OF LIFE AND DIABETES RELATED SYMPTOMS WHEN RECEIVING SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR VERSUS OTHER NONINULIN DIABETES MEDICATIONS. Journal Of The American College Of Cardiology 2022, 79: 1547. DOI: 10.1016/s0735-1097(22)02538-4.Peer-Reviewed Original Research
2017
Ketamine: A Promising Rapid-Acting Antidepressant
Wilkinson S, Ostroff R, Katz R, Krystal J. Ketamine: A Promising Rapid-Acting Antidepressant. 2017, 223-239. DOI: 10.1007/978-981-10-6577-4_16.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMood disordersDeficiency hypothesisInitiation of therapyRapid antidepressant effectsRapid acting antidepressantsEvidence-based treatmentsLong-term riskMood disorders researchRelapse prevention strategiesEfficient therapeutic targetMechanism of actionOral antidepressantsAntidepressant effectsGlutamatergic receptorsGlutamatergic systemNovel antidepressantsSingle doseClinical trialsKetamine exposureRelated symptomsLong-term effectsPsychiatric disordersPrevention strategiesTherapeutic targetDrug AdministrationAnxiety Disorders
Weems C, Silverman W. Anxiety Disorders. 2017, 531-559. DOI: 10.1002/9781394258932.ch16.Peer-Reviewed Original ResearchAnxiety disordersChildhood anxiety disordersInformation processing modelDevelopmental psychopathology approachStages of cognitionInternalizing symptomsHeritable vulnerabilityAnxious symptomsProcessing modelSomatic complaintsLatino childrenNon-Latino childrenHigh levelsClinical samplesDisordersChildrenLarge bodyRelated symptomsCognitionAnxietySymptomsEthnic differencesYouthPotential factorsGirls
2014
Sleep in Patients with Restrictive Lung Disease
Won CH, Kryger M. Sleep in Patients with Restrictive Lung Disease. Clinics In Chest Medicine 2014, 35: 505-512. PMID: 25156766, DOI: 10.1016/j.ccm.2014.06.006.ChaptersConceptsRestrictive lung diseaseLung diseaseObesity hypoventilation syndromeInterstitial lung diseasePathophysiology of sleepImpact of treatmentOverall prognosisVentilatory defectHypoventilation syndromeImpaired ventilationDaytime fatigueSleep disruptionRelated symptomsSleep disordersSleep qualityDiffusion impairmentNeuromuscular diseaseDiseasePatientsPathophysiologySleepHypoxemiaHypercarbiaPrognosisDysfunctionThe impact of gender on timeliness of narcolepsy diagnosis.
Won C, Mahmoudi M, Qin L, Purvis T, Mathur A, Mohsenin V. The impact of gender on timeliness of narcolepsy diagnosis. Journal Of Clinical Sleep Medicine 2014, 10: 89-95. PMID: 24426826, PMCID: PMC3869076, DOI: 10.5664/jcsm.3370.Peer-Reviewed Original ResearchConceptsMultiple sleep latency testingLifestyle impairmentSymptom onsetConsecutive patientsUniversity Sleep Disorders CenterSleep latency testingSleep disorders centerEpworth Sleepiness ScaleCross-sectional studyTimeliness of diagnosisImpact of genderDelay diagnosisLatency testingNarcolepsy diagnosisNarcoleptic patientsDisorders CenterRelated symptomsSleepiness ScaleMedical conditionsPhysical activityWomen's healthObjective sleepinessSleep habitsPatientsDiagnosis
2013
Psychoeducational Interventions: What Every Parent and Family Member Needs to Know
Lebowitz E, Scahill L. Psychoeducational Interventions: What Every Parent and Family Member Needs to Know. 2013, 487-502. DOI: 10.1093/med/9780199796267.003.0022.Peer-Reviewed Original ResearchParents of childrenSocial victimizationSocial difficultiesPeer victimizationPsychoeducational interventionEmotional challengesPsychoeducationSchool staffVictimizationSuch discriminationParentsTourette syndromeChildrenRelated symptomsDiscriminationFamily membersDifficultiesPeersWorkplaceDifferent featuresImportant aspectAdultsIndividualsInterventionEmployers
2009
Manipulative Therapy for Pregnancy and Related Conditions
Khorsan R, Hawk C, Lisi AJ, Kizhakkeveettil A. Manipulative Therapy for Pregnancy and Related Conditions. Obstetrical & Gynecological Survey 2009, 64: 416-427. PMID: 19445815, DOI: 10.1097/ogx.0b013e31819f9ddf.Peer-Reviewed Original ResearchConceptsSpinal manipulative therapyManipulative therapyBack painRelated symptomsUse of SMTPregnancy-related back painScottish Intercollegiate Guidelines NetworkNatural Therapy Index SystemInitial search strategyTypes of symptomsCumulated IndexPregnant patientsCochrane LibraryTreatment optionsBody of evidenceSTUDY SELECTIONMethodological qualityChiropractic GuidelinesEffective treatmentFamily physiciansPractice parametersCitation listsPeer-reviewed manuscriptsPregnancyHand search
2005
Measuring Change in OCD: Sensitivity of the Obsessive-Compulsive Inventory-Revised
Abramowitz J, Tolin D, Diefenbach G. Measuring Change in OCD: Sensitivity of the Obsessive-Compulsive Inventory-Revised. Journal Of Psychopathology And Behavioral Assessment 2005, 27: 317-324. DOI: 10.1007/s10862-005-2411-y.Peer-Reviewed Original ResearchObsessive-Compulsive InventoryYale-Brown Obsessive Compulsive ScaleMeasures of OCDCognitive behavioral therapySelf-report measuresObsessive-compulsive disorder severityObsessive Compulsive ScaleResponse preventionOCD symptomsNaturalistic outcome studyOCD patientsDisorder severityGlobal functioningCompulsive ScaleOCDRelated symptomsSymptom InterviewOCIInventoryOutcome studiesTreatment effectsAnxietyMeasuresRevisedFunctioning
2003
Support and Coronary Heart Disease: The Importance of Significant Other Responses
Itkowitz NI, Kerns RD, Otis JD. Support and Coronary Heart Disease: The Importance of Significant Other Responses. Journal Of Behavioral Medicine 2003, 26: 19-30. PMID: 12690944, DOI: 10.1023/a:1021790921471.Peer-Reviewed Original ResearchConceptsCHD symptomsSymptom severityCoronary heart diseaseDegree of disabilityDepressive symptom severityHealth-related disordersLevel of symptomsSymptomatic CHDChronic painCoronary heartHeart diseaseRelated symptomsSelf-report questionnairesDepressive symptomsSymptom occurrenceSymptomsConcomitant disabilitiesEmotional distressRegression analysisCHDDisabilitySocial supportSeverityOperant conditioning modelExpression
1999
Olanzapine Treatment of Children, Adolescents, and Adults with Pervasive Developmental Disorders
Potenza M, Holmes J, Kanes S, McDougle C. Olanzapine Treatment of Children, Adolescents, and Adults with Pervasive Developmental Disorders. Journal Of Clinical Psychopharmacology 1999, 19: 37-44.. PMID: 9934941, DOI: 10.1097/00004714-199902000-00008.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderClinical Global Impression ScaleWeight gainTolerability of olanzapineLiver function abnormalitiesExtrapyramidal side effectsGlobal Impression ScaleGlobal improvement itemTreatment of childrenSignificant adverse effectsDevelopmental disordersSelf-injurious behaviorClinical respondersOlanzapine treatmentFunction abnormalitiesDaily doseOverall symptomsPatient populationImpression ScalePrincipal diagnosisMotor restlessnessProspective fashionWeek 4Related symptomsSide effects
1997
Improvement in Interstitial Cystitis Symptom Scores During Treatment With Oral L-Arginine
Smith S, Wheeler M, Foster H, Weiss R. Improvement in Interstitial Cystitis Symptom Scores During Treatment With Oral L-Arginine. Journal Of Urology 1997, 158: 703-708. DOI: 10.1016/s0022-5347(01)64297-6.Peer-Reviewed Original ResearchConceptsOral L-arginineL-arginineInterstitial cystitisInterstitial Cystitis Symptom ScoreNitric oxide synthase activityLower abdominal painInterstitial cystitis symptomsL-arginine treatmentOxide synthase activityNitric oxide synthaseSelf-controlled studyAbdominal painUrethral painUrinary frequencyCystitis symptomsSymptom scoresMethodsTen patientsOxide synthaseRelated symptomsImmunological responseNitric oxidePatientsSymptomsSignificant decreaseCystitisImprovement in Interstitial Cystitis Symptom Scores During Treatment With Oral L-Arginine
Smith S, Wheeler M, Foster H, Weiss R. Improvement in Interstitial Cystitis Symptom Scores During Treatment With Oral L-Arginine. Journal Of Urology 1997, 158: 703-708.. PMID: 9258064, DOI: 10.1097/00005392-199709000-00005.Peer-Reviewed Original ResearchConceptsOral L-arginineL-arginineInterstitial cystitisUrinary nitric oxide synthase activityInterstitial Cystitis Symptom ScoreOral L-arginine treatmentNitric oxide synthase activityLower abdominal painInterstitial cystitis symptomsMethods Ten patientsL-arginine treatmentOxide synthase activityNitric oxide synthaseSelf-controlled studyAbdominal painTEN patientsUrethral painUrinary frequencyCystitis symptomsSymptom scoresOxide synthaseRelated symptomsImmunological responseNitric oxidePatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply